The Rainbow Study - the Effect of Feedback on Asthmatic Symptom Perception

NCT ID: NCT06702735

Last Updated: 2024-11-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

39 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-10-16

Study Completion Date

2025-05-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Asthma is a common childhood disease that is characterized by chronic airway inflammation and episodic expiratory airflow obstruction. Asthma symptoms can impair participation in play and sports and have a negative impact on quality of life. It can be challenging for children to adequately feel and report their symptoms. Some children experience more symptoms than expected based on lung function during these symptoms, whereas others experience less symptoms than expected. This is also called 'symptom perception'.

A tool was developed to visualize symptoms, lung function and accessory symptom perception: The Rainbow tool. The aim of this study was to identify asthmatic children with a poor perception and investigate if their symptom perception could be improved by regular lung function measurements and personal feedback based on the Rainbow Tool.

Hypothesis: Measuring lung function en symptoms and provide personal feedback on perception based on the Rainbow tool has a positive effect on perception of asthma-related symptoms in asthmatic children.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Asthma is a common childhood disease that is characterized by chronic airway inflammation and episodic expiratory airflow obstruction. Asthma symptoms can impair participation in play and sports and have a negative impact on quality of life. It can be challenging for children to adequately feel and report their symptoms. Some children experience more symptoms than expected based on lung function during these symptoms, whereas others experience less symptoms than expected. This is also called 'symptom perception'.

A tool was developed to visualize symptoms, lung function and accessory symptom perception: The Rainbow tool. The Rainbow tool is a two-dimensional color-coded plot, visualizing the relationship between lung function, denoted as a percentage of personal best (FEV1) on the vertical axis, and VAS score on the horizontal axis. The FEV1 as a percentage of personal best on the vertical axis ranges from 30% to 100% since a maximal VAS score would be expected with a change in FEV1 to ≤ 30% of personal best. The horizontal axis ranges from 0 to 10, with 0 indicating no dyspnea and 10 maximal dyspnea. There are four color-coded zones: the green zone, yellow zone, orange zone, and red zone. The green zone indicates good alignment between symptoms and lung function, and thus a good symptom perception. It forms a diagonal band from the upper left (around 100% FEV1 and VAS score of 0) stretching to the lower right (around 30% FEV1 and VAS score of 10). The green zone is followed by the yellow, orange, and red zones on either side, indicating an increasing deviation in symptom perception from the ideal and respectively mild, moderate, and severe disconcordance between FEV1 and VAS score. The aim of this study was to identify asthmatic children with a poor perception and investigate if their symptom perception could be improved by regular lung function measurements and personal feedback based on the Rainbow Tool.

Hypothesis: Measuring lung function en symptoms and provide personal feedback on perception based on the Rainbow tool has a positive effect on perception of asthma-related symptoms in asthmatic children.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Asthma in Children Exercise Induced Asthma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

This study is a prospective, non-blinded randomized controlled trial with three parallel arms. After a selection phase of 2 weeks, eligible participants were equally allocated to the study arms (ratio 1:1:1). The intervention phase consists of three weeks, followed by a follow-up of two weeks.
Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention group (with feedback)

Collection of VAS scores and lung function. Explanation about the Rainbow tool to visualize symptom perception, and use of this tool during intervention phase. Feedback sessions with health care professional to evaluate symptom perception using the Rainbow tool.

Group Type EXPERIMENTAL

Rainbow tool

Intervention Type BEHAVIORAL

The Rainbow tool visualizes perception based on lung function measurements and VAS scores.

Feedback

Intervention Type BEHAVIORAL

Feedback sessions with health care professional based on the Rainbow tool.

Intervention group (without feedback)

Collection of VAS scores and lung function. Explanation about the Rainbow tool to visualize symptom perception, and use of this tool during intervention phase.

Group Type EXPERIMENTAL

Rainbow tool

Intervention Type BEHAVIORAL

The Rainbow tool visualizes perception based on lung function measurements and VAS scores.

Control group

Collection of VAS scores and lung function. No additional intervention.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Rainbow tool

The Rainbow tool visualizes perception based on lung function measurements and VAS scores.

Intervention Type BEHAVIORAL

Feedback

Feedback sessions with health care professional based on the Rainbow tool.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Selection phase:

* Pediatrician diagnosed asthma
* Health care professional thinks perception might be poor
* Age 7 until 15 years old
* Adequate understanding of Dutch language

Intervention phase:

* Adequate number of lung function measurements + VAS scores during selection phase, defined as:
* At least 4 measurements after exercise or when experiencing symptoms and
* At least 2 standard measurements
* Poor perception during selection phase, defined as:
* At least 1 measurement in red zone on Perception Rainbow and/or
* At least 2 measurements in orange zone on Perception Rainbow and/or
* Average of all measurements after exercise or when experiencing symptoms in yellow zone (or orange/red)and/or
* Average of all measurements in yellow zone (or orange/red)

Exclusion Criteria

* Severe comorbidity (for example psychomotor retardation or severe cardiopulmonary conditions)
* Not able to fill in VAS score (for example due to blindness)
* Not able to perform technically correct spirometry manoeuvres
* Medication change in past 2 weeks
* Exacerbation which required oral prednisone in the past 6 weeks
* Exacerbation at the moment of inclusion
* No device (computer, tablet or smartphone) with internet connection available at home
Minimum Eligible Age

7 Years

Maximum Eligible Age

15 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Medisch Spectrum Twente

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Vera Hengeveld, MD

Role: PRINCIPAL_INVESTIGATOR

Medisch Spectrum Twente

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Medisch Spectrum Twente

Enschede, Overijssel, Netherlands

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Netherlands

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Vera Hengeveld, MD

Role: CONTACT

+31534872310

Mattienne van der Kamp, MSc, PhD

Role: CONTACT

+31534872310

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Vera Hengeveld, MD

Role: primary

+316534872310

Mattienne van der Kamp, MSc

Role: backup

+316534872310

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RAINBOW study

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Microglia Activation in Asthma
NCT04307667 RECRUITING
Controlling Asthma at School
NCT00005735 COMPLETED
Exercise Rehabilitation for Children With Asthma
NCT06272604 NOT_YET_RECRUITING NA